Health News Roundup: AstraZeneca Lifts COVID Treatment Revenue Forecast; US strikes $1.74 billion deal with Moderna for updated COVID vaccine and more


Here is a summary of health news briefs.

Bristol Myers drug combo fails to meet primary goal of kidney cancer trial

Bristol Myers Squibb said on Friday that a trial evaluating a combination of its two cancer drugs failed to achieve the primary goal of treating localized kidney cancer. The combination of the two drugs – Yervoy and top-selling cancer drug Opdivo – is already approved in the United States as a first-line treatment for patients with renal cell carcinoma that has spread.

Austria mourns suicide of doctor targeted by anti-vaccine activists

Austrian leaders have called for national unity after a doctor threatened with death by anti-vaccination activists and coronavirus pandemic conspiracy theorists killed himself.

“Let’s put an end to this intimidation and this campaign of fear. Hate and intolerance have no place in our Austria,” said President Alexander Van der Bellen, hailing Lisa-Maria Kellermayr as a doctor who s is fighting to heal people, protect them from disease and take a cautious approach to the pandemic.

AstraZeneca lifts revenue forecast on COVID treatment

AstraZeneca said it expected prescriptions for its COVID therapy to drive sales growth of more than 20% this year, as the company reported second-quarter profit that beat analysts’ estimates. The injection, called Evusheld, which is designed to protect against COVID infection for at least six months, has been rolled out in many countries for people with weakened immune systems who see little or no benefits of vaccines.

US strikes $1.74 billion deal with Moderna for updated COVID vaccine

The U.S. government said on Friday it had accepted a $1.74 billion deal for 66 million doses of an updated Moderna Inc COVID vaccine for the Omicron subvariant to be used in a drug recall campaign. fall and winter, pushing Moderna’s shares up 3%. Combined with the 105 million doses the government has already agreed to purchase from Pfizer Inc and its partner BioNTech SE for $3.2 billion, the latest deal brings the US supply of booster doses to approximately 171 million doses. .

AbbVie will pay up to $2.37 billion to settle US opioid claims

AbbVie Inc has agreed to pay up to $2.37 billion to resolve thousands of U.S. lawsuits against its Allergan unit for marketing opioid painkillers, state officials said Friday. If finalized, the agreement could end more than 3,000 lawsuits from state and local governments across the country. It includes settlements the drugmaker has already reached with states, including $200 million for New York.

If you’re at high risk, don’t wait for updated COVID vaccines, experts say

People at high risk of severe illness who have not yet received a second COVID-19 booster should not wait for next-generation vaccines targeting Omicron due in the fall, five vaccine experts told Reuters. In many countries, including the United States, the BA.5 Omicron subvariant of the virus is thriving, but current vaccines continue to provide protection against hospitalization for severe illness and death.

CanSinoBIO’s Inhaled COVID Booster Is Stronger Against BA.1 Omicron Subvariant Than Sinovac’s Shot

The inhalation-based candidate from Chinese vaccine company CanSino Biologic elicited a better antibody response as a booster against the BA.1 Omicron subvariant than Sinovac’s vaccine, but the antibody level dropped within a few months, according to clinical trial data. The result came as top Chinese political leaders called for proper monitoring of the virus mutation and the development of new vaccines and treatments in the country’s efforts to fine-tune its COVID control strategy.

New York Governor Hochul declares a state of emergency over monkeypox

On Friday evening, New York State Governor Kathy Hochul declared a state of emergency in the state due to the continued spread of monkeypox. “I am declaring a State Disaster Emergency to bolster our ongoing efforts to deal with the monkeypox outbreak,” Hochul tweeted.

Spain reports second death linked to monkeypox in Europe

Spain reported its second monkeypox-related death on Saturday, in what is thought to be the second fatality from the disease in Europe and only the third outside Africa in the current outbreak. Spain had reported its first death as recently as Friday, shortly after Brazil reported the first monkeypox-related death outside the African continent in the current wave of the disease.

Brazil reports first death from monkeypox outside of Africa in current outbreak

Brazil reported the first monkeypox-related death outside the African continent in the current outbreak on Friday, shortly before Spain confirmed the first known death in Europe in the outbreak later in the day. The Brazilian victim was a 41-year-old man who the health ministry said also suffered from lymphoma and a weakened immune system.

(With agency contributions.)


Comments are closed.